Julia Katrina Boltz

What are the key objectives being pursued by decision-makers in German corporates and private equity firms in their deal considerations and what challenges will they face in 2025? Get valuable insights in our 2025 M&A Outlook. https://lnkd.in/dtmE69zU

25

🌍 Ready to see how cutting-edge technology is reshaping private equity? Join us as we explore how GenAI is driving smarter, faster, and more impactful decisions across the PE landscape. In our latest PE webcast, experts Patrick Devine, Thomas Pflegel and Dr. Pascal du Bosque will share actionable insights on the transformative role of GenAI in PE. From fund-level strategy to portfolio impact. What We’ll Cover:  ✨ 𝗚𝗲𝗻𝗔𝗜 𝗶𝗻 𝗔𝗰𝘁𝗶𝗼𝗻 – How GenAI is enhancing decision-making for funds, deals, and portfolio companies.  ✨ 𝗣𝗿𝗶𝗼𝗿𝗶𝘁𝗶𝘇𝗶𝗻𝗴 𝗔𝗜 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 – How to identify and scale AI use cases that maximize portfolio value.  ✨ 𝗣𝗿𝗼𝗼𝗳-𝗼𝗳-𝗖𝗼𝗻𝗰𝗲𝗽𝘁𝘀 𝘁𝗵𝗮𝘁 𝗪𝗼𝗿𝗸 – Real-world GenAI solutions driving success in specific industries and segments. If you’re looking to stay competitive in an evolving market, this is an opportunity not to miss. 📅 Date: 21 November 2024  ⏰ Time: 10-11am CET  📍 Register here: https://lnkd.in/ept4DsYw #PrivateEquity #GenAI #DueDiligence #ValueCreation #Innovation #TransactToTransform #StrategicInsights #FutureofPE

13

Our latest thinking on SG&A costs optimization for EPC players.

12

1 Kommentar

In addition to #EPC revenue streams and project backlog, the ability to manage sales and general costs is becoming even more crucial in this market scenario. Our Roland Berger STEP Change expertise unlocks consistent profitability and frees up resources for further growth. Please read Sven Siepen's post below. We are keen to discuss it further. Leonardo Bonetti, Peter Odenwälder, Stefan Krieger, Slava Chak, Tim Longstaff, Gareth Hayes

5

What are the key objectives being pursued by decision-makers in German corporates and private equity firms in their deal considerations and what challenges will they face in 2025? Get valuable insights in our 2025 M&A Outlook. https://lnkd.in/eF5tAhcj

3

Five building blocks can help Germany build a stronger foundation to expand private equity investment, creating value, employment, and economic growth.

1

Dive into the world of transfer pricing with Balazs Karancsi and Markus Hahn from KPMG Switzerland! Discover how they create value for you by helping you navigate the complexities of intragroup financing structures. Tune in for insightful advice and pragmatic solutions tailored to your business needs. #TransferPricing #FinancingTransactions

3

Heading to Berlin for this year´s SuperReturn next week and looking for profit levers to boost your portfolio? Let´s meet up!   SuperReturn International in Berlin is a major conference and networking event for leaders in private equity and venture capital from June 4-7, 2024. If you wish to discuss how to improve your portfolio with tangible sales and pricing levers simply contact me! All the best from Berlin.   #PrivateEquity #Marketintelligence #Networking #Berlin

23

All tax free now? 👀 No, that is of course not the case. But the Future Financing Act changed a couple rules when dealing with real shares for employees. So there is a chance of benefiting from capital gains tax rather than (only) employment income. Does that mean VSOP is no longer state of the art? Well... read more in the article 👇 .... and reach out in case of any questions ❔ #ESOPasap #EIP #SharePlans #EY #EYGlobalEquity #attracttalent #createvalue #sharesuccess

64

𝐖𝐎𝐖! 🤩 Excited that our study on 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐌𝐨𝐝𝐞𝐥 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 is ranked among the 𝐓𝐨𝐩 𝟓 most cited publications in Entrepreneurship Theory and Practice (VHB: A, AJG: 4). 🌟🎊 Utilizing extensive quantitative data from German firms, this study is the first in a Financial Times 𝟓𝟎 𝐥𝐢𝐬𝐭 journal to explain the relationship between 𝐨𝐰𝐧𝐞𝐫𝐬𝐡𝐢𝐩 and 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧. We're thrilled to be ranked in the 𝐓𝐨𝐩 𝟓 among the 𝐦𝐨𝐬𝐭 𝐜𝐢𝐭𝐞𝐝 ETP articles over the 𝐩𝐚𝐬𝐭 𝐭𝐡𝐫𝐞𝐞 𝐲𝐞𝐚𝐫𝐬. A huge shoutout to my outstanding co-authors Ivan Miroshnychenko, Dr. Nadine Kammerlander, and Alfredo De Massis! 🙌 Our 𝐤𝐞𝐲 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 include... 🔍 ⚙️ A positive relationship between 𝐟𝐚𝐦𝐢𝐥𝐲 𝐢𝐧𝐟𝐥𝐮𝐞𝐧𝐜𝐞 and 𝐝𝐢𝐠𝐢𝐭𝐚𝐥 𝐁𝐌𝐈, challenging the so far pessimistic views on discontinuous innovation in family-influenced firms. 💡 This relationship is mediated by 𝐝𝐲𝐧𝐚𝐦𝐢𝐜 𝐜𝐚𝐩𝐚𝐛𝐢𝐥𝐢𝐭𝐢𝐞𝐬, especially in 𝘬𝘯𝘰𝘸𝘭𝘦𝘥𝘨𝘦 𝘮𝘢𝘯𝘢𝘨𝘦𝘮𝘦𝘯𝘵, 𝘳𝘪𝘴𝘬 𝘮𝘢𝘯𝘢𝘨𝘦𝘮𝘦𝘯𝘵, and 𝘮𝘢𝘳𝘬𝘦𝘵𝘪𝘯𝘨 𝘤𝘢𝘱𝘢𝘣𝘪𝘭𝘪𝘵𝘪𝘦𝘴. 🚀 Notably, the positive impact of family influence on dynamic capabilities is weakened rather than strengthened by 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭𝐚𝐥 𝐝𝐲𝐧𝐚𝐦𝐢𝐬𝐦. #digitalBMI #businessmodelinnovation #digitalinnovation #innovation #digitaltransformation #research #familybusiness #familyinfluence #dynamiccapabilities

107

20 Kommentare

Two cities, one theme: Compliance Monitoring. Join us in Hannover or Eschborn to discuss how you can effectively monitor and adapt your CMS despite limited resources. Registration is open. Hannover: https://go.ey.com/4ckRiVf Eschborn: https://go.ey.com/4chtvp6 #EYForensics #CCompliance #Monitoring

1

I always love listening to Dr. Thomas Solbach's latest #StrategyandInsider podcast. This time even more since my friend Clemens Utschig-Utschig, MBA, CTO at Boehringer Ingelheim shares his view on how #data can drive personalized #healthcare! Please follow Thomas and Clemens when they discuss the key #technologies shaping #pharma's future and the major hurdles to #innovation. Learn why #quantumcomputing is at the forefront, how long it will take to see real-world application, and what other promising technologies will shape the future of health: https://lnkd.in/dUaQw8fR Roland Werner, Dr. Jens Neumann, Dr. Matthias Schlemmer, Strategy&, Jan-Philipp Loch, Markus Schümmelfeder, Bhawna Paul, Andreas Henrich.

44

3 Kommentare

🚀 Unveiling the Potential of AI in Biotech! 🧬   As an author featured in the recently launched EY German Biotech Report 2024, I'm thrilled to share a glimpse into the future of biotechnology. This year’s edition is packed with cutting-edge insights and transformative trends that are shaping the industry. 🔍 Dive into my article and join me in exploring how AI is not just a tool, but a game-changer for biotech. 📥 Download the full report now and immerse yourself in the world of biotech possibilities: https://lnkd.in/e_dv7xMW 💡 Got questions or want to discuss the insights further? Drop a comment below and let's spark a conversation!   #EYBiotech #BioDeutschland #Biotechnologie #ResponsibleAI #AIRisk

14

1 Kommentar

𝐈𝐬 𝐲𝐨𝐮𝐫 𝐀𝐈 𝐠𝐨𝐯𝐞𝐫𝐧𝐚𝐧𝐜𝐞 𝐩𝐫𝐞𝐩𝐚𝐫𝐞𝐝 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞? 🌐 As #AI technologies evolve, organisations face unprecedented opportunities but also new challenges and new or amplified risks. Our latest article looks into a pragmatic approach to establishing AI governance frameworks to ensure ethical AI deployment and compliance with regulatory standards, emphasising the importance of diverse teams, continuous monitoring, and stakeholder engagement. What steps are you taking to ensure your governance framework effectively addresses these complexities? 🤔🤖 Read more about setting up an effective AI governance 👉 https://deloi.tt/48e2lPq #AIGovernance #EthicalAI

5

At Roland Berger's Capital Goods client team, we are intensively supporting #EPC companies - since more than 20 years already. In our projects we often see that #SG&A costs are overlooked. While the primary focus is on optimizing project-specific outcomes, the steady increase in (often non-reimbursable!) #SG&A costs suggests a significant opportunity to improve overall profitability. Our experience shows that addressing SG&A systematically can unlock significant profitability. Roland Berger’s proprietary STEP Change approach has consistently delivered measurable results, both within the EPC sector and beyond, by focusing on sustainable profitability gains.   Please find some more details attached and get in touch with the team when you are interested to discuss how STEP Change can enhance profitability at your company while achieving your strategic goals. Peter Odenwälder Stefan Krieger Leonardo Bonetti Francesco Campagna Slava Chak Tim Longstaff Houda O. Gareth Hayes Clement Audouin

33

Companies that do more M&A deliver better shareholder returns, as the data has proven again and again. But what do those that succeed at integration do differently? And how can companies with bold M&A ambitions but less of a track record keep up? Explore the 10 key steps we’ve identified that the best integrators consistently follow. https://atbain.co/4bKbaBz

3

Companies that do more M&A deliver better shareholder returns, as the data has proven again and again. But what do those that succeed at integration do differently? And how can companies with bold M&A ambitions but less of a track record keep up? Explore the 10 key steps we’ve identified that the best integrators consistently follow. https://atbain.co/4bKbaBz

2

Are you curious about the #consulting industry? Then join our virtual get-together and network with us #Bainies. Dive into the world of consulting and get insider tips on shaping your own career. #MeetUs

1